Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism CTNNB inhibitors(Beta catenins inhibitors), GSK-3β inhibitors(Glycogen synthase kinase-3 beta inhibitors), HDAC inhibitors(Histone deacetylase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 1 | Discovery | - | 19 Aug 2025 | |
| Myelodysplastic Syndromes | Discovery | - | 19 Aug 2025 | |
| Neoplasms | Discovery | - | 19 Aug 2025 |





